Oren Livnat

Stock Analyst at HC Wainwright & Co.

(4.54)
# 269
Out of 5,030 analysts
140
Total ratings
52.59%
Success rate
23.62%
Average return

Stocks Rated by Oren Livnat

Pacira BioSciences
Apr 8, 2025
Maintains: Buy
Price Target: $48$65
Current: $22.78
Upside: +185.34%
Verrica Pharmaceuticals
Apr 8, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.23
Upside: -
Collegium Pharmaceutical
Mar 24, 2025
Reiterates: Buy
Price Target: $50
Current: $33.21
Upside: +50.56%
Trevi Therapeutics
Mar 19, 2025
Reiterates: Buy
Price Target: $13
Current: $10.63
Upside: +17.59%
ANI Pharmaceuticals
Mar 17, 2025
Reiterates: Buy
Price Target: $94
Current: $91.95
Upside: +2.23%
Zevra Therapeutics
Mar 13, 2025
Reiterates: Buy
Price Target: $20
Current: $11.38
Upside: +75.75%
Jazz Pharmaceuticals
Mar 10, 2025
Maintains: Buy
Price Target: $200$217
Current: $134.25
Upside: +61.64%
Xeris Biopharma Holdings
Mar 7, 2025
Reiterates: Buy
Price Target: $6.6$8
Current: $9.14
Upside: -12.47%
Avadel Pharmaceuticals
Mar 4, 2025
Reiterates: Buy
Price Target: $21
Current: $15.00
Upside: +40.00%
Tarsus Pharmaceuticals
Feb 26, 2025
Reiterates: Buy
Price Target: $73
Current: $74.97
Upside: -2.63%
Reiterates: Buy
Price Target: $12
Current: $3.21
Upside: +273.83%
Reiterates: Buy
Price Target: $7.5
Current: $5.35
Upside: +40.19%
Maintains: Buy
Price Target: $14$8
Current: $0.81
Upside: +892.80%
Maintains: Buy
Price Target: $43$60
Current: $3.11
Upside: +1,813.18%
Maintains: Buy
Price Target: $252$198
Current: $0.36
Upside: +54,762.84%